ePlex BCID Panels offer the broadest coverage of organisms and resistance markers that can lead to sepsis, including anaerobes and multidrug resistant organisms (MDRO), as well as common and emerging fungal pathogens. The ePlex BCID Fungal Pathogen (FP) Panel is the only multiplex molecular panel to include Candida auris, an MDRO of increasing prevalence BCID Panels aid clinicians in the identification of bacterial and fungal organisms as well as antibiotic resistance genes within approximately 1.5 hours of blood bottle positivity, allowing treatment decisions to occur days earlier than with conventional methods.